Supernus Pharmaceuticals Correlations

SUPN Stock  USD 36.57  0.42  1.14%   
The current 90-days correlation between Supernus Pharmaceuticals and Intracellular Th is 0.11 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Supernus Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Supernus Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Supernus Pharmaceuticals Correlation With Market

Very weak diversification

The correlation between Supernus Pharmaceuticals and DJI is 0.41 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Supernus Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Supernus Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
To learn how to invest in Supernus Stock, please use our How to Invest in Supernus Pharmaceuticals guide.

Moving together with Supernus Stock

  0.78FNMFO Federal National MortgagePairCorr
  0.61KB KB Financial GroupPairCorr
  0.65CSCO Cisco Systems Sell-off TrendPairCorr
  0.81BAC Bank of America Aggressive PushPairCorr
  0.68CVX Chevron Corp Sell-off TrendPairCorr

Moving against Supernus Stock

  0.87HLN Haleon plcPairCorr
  0.74PFE Pfizer Inc Aggressive PushPairCorr
  0.67BCH Banco De ChilePairCorr
  0.65ANRO Alto Neuroscience,PairCorr
  0.59JNJ Johnson Johnson Sell-off TrendPairCorr
  0.53SHG Shinhan FinancialPairCorr
  0.43BAC-PL Bank of AmericaPairCorr
  0.31WF Woori Financial GroupPairCorr
  0.69MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.62VZ Verizon Communications Sell-off TrendPairCorr
  0.32MSFT Microsoft Aggressive PushPairCorr

Related Correlations Analysis

Please specify at least 3 valid symbols having historical data to build a meaningful correlation cloud. You can use symbol search above to locate your securities.

Supernus Pharmaceuticals Corporate Management

Padmanabh BhattChief Scientific Officer and Sr. VP of Intellectual PropertyProfile
Tami MartinVP AffairsProfile
Jeff BozickSenior ChainProfile
Kevin EsqCompliance OfficerProfile
Taylor RaifordSenior SalesProfile
Bryan RoeckleinSenior DevelopmentProfile